Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America.
Independent Software Developer, Ann Arbor, MI, United States of America.
PLoS One. 2024 May 16;19(5):e0300005. doi: 10.1371/journal.pone.0300005. eCollection 2024.
Strategies to prevent or delay Alzheimer's disease and related dementias (AD/ADRD) are urgently needed, and blood pressure (BP) management is a promising strategy. Yet the effects of different BP control strategies across the life course on AD/ADRD are unknown. Randomized trials may be infeasible due to prolonged follow-up and large sample sizes. Simulation analysis is a practical approach to estimating these effects using the best available existing data. However, existing simulation frameworks cannot estimate the effects of BP control on both dementia and cardiovascular disease. This manuscript describes the design principles, implementation details, and population-level validation of a novel population-health microsimulation framework, the MIchigan ChROnic Disease SIMulation (MICROSIM), for The Effect of Lower Blood Pressure over the Life Course on Late-life Cognition in Blacks, Hispanics, and Whites (BP-COG) study of the effect of BP levels over the life course on dementia and cardiovascular disease. MICROSIM is an agent-based Monte Carlo simulation designed using computer programming best practices. MICROSIM estimates annual vascular risk factor levels and transition probabilities in all-cause dementia, stroke, myocardial infarction, and mortality in a nationally representative sample of US adults 18+ using the National Health and Nutrition Examination Survey (NHANES). MICROSIM models changes in risk factors over time, cognition and dementia using changes from a pooled dataset of individual participant data from 6 US prospective cardiovascular cohort studies. Cardiovascular risks were estimated using a widely used risk model and BP treatment effects were derived from meta-analyses of randomized trials. MICROSIM is an extensible, open-source framework designed to estimate the population-level impact of different BP management strategies and reproduces US population-level estimates of BP and other vascular risk factors levels, their change over time, and incident all-cause dementia, stroke, myocardial infarction, and mortality.
预防或延缓阿尔茨海默病和相关痴呆症(AD/ADRD)的策略迫在眉睫,血压(BP)管理是一种很有前途的策略。然而,不同的生命历程中的 BP 控制策略对 AD/ADRD 的影响尚不清楚。由于需要长期随访和大量的样本量,随机试验可能不可行。模拟分析是使用现有最佳数据估计这些影响的实用方法。然而,现有的模拟框架无法估计 BP 控制对痴呆症和心血管疾病的影响。本文描述了一种新的人群健康微观模拟框架——密歇根慢性疾病模拟(MICROSIM)的设计原则、实现细节和人群水平验证,用于评估生命历程中的 BP 控制对黑种人、西班牙裔和白种人晚年认知的影响(BP-COG)研究。MICROSIM 是一种基于代理的蒙特卡罗模拟,使用计算机编程最佳实践进行设计。MICROSIM 使用全国健康和营养检查调查(NHANES)中 18 岁以上美国成年人的全国代表性样本,估计所有原因痴呆、中风、心肌梗死和死亡率的年度血管风险因素水平和转移概率。MICROSIM 使用来自 6 项美国前瞻性心血管队列研究的个体参与者数据的汇总数据集来模拟认知和痴呆的变化。心血管风险使用广泛使用的风险模型进行估计,BP 治疗效果源自随机试验的荟萃分析。MICROSIM 是一个可扩展的开源框架,旨在估计不同 BP 管理策略的人群水平影响,并重现美国人群水平的 BP 和其他血管风险因素水平及其随时间的变化,以及全因痴呆、中风、心肌梗死和死亡率的发生。